Smoking Cessation Program Following Diagnosis of a Potentially Curable Cancer
- Conditions
- Potentially curable cancer (any type)Cancer -
- Registration Number
- ACTRN12606000190505
- Lead Sponsor
- Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Signed informed consent- presence of a potentially curable cancer which is newly diagnosed and histologically confirmed- treatment policy established for curative intent- current smoker or recent ex smoker- ability to participate in the first interview with a quit counsellor within a week of registration- high likelihood of surviving for at least 12 months- available for 12 month follow up- ability to speak, read and write English sufficiently well- access to a telephone at home.
Inital treatment for cancer commenced more than two weeks prior to study registration- active current history of unstable psychiatric illness or significant cognitive deficits.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prolonged abstience rate[At 12 months]
- Secondary Outcome Measures
Name Time Method Determine prolonged abstinence [At 1, 3 and 6 months];Determine point-prevalence abstinence rates [At 1, 3, 6, and 12 months];Assess associations between prolonged abstinence status at 12 months and level of nicotine dependence, demongraphic factors, type of cancer, patient readiness to abstain, distress score, quality of life, efficacy of inital anti-cancer treatment, toxicity of inital anti-cancer treatment.[];Compare quitters and non-quitters with respect to change in quality of life and distress[];Identify barriers and difficulties in the quitting process[]